This session will contain presentations on the Combating Antibiotic Resistant Bacteria (CARB) and the Advanced Molecular Detection (AMD) initiatives currently being performed at CDC. CARB is in its first year of implementation with a number of planning funding streams. The AMD initiative, now completing Year 3, is to bring next-generation sequencing, bioinformatics and related technology into public health in the United States. Both programs are expected to have a large impact in several areas of public health, including antimicrobial resistance, bacterial foodborne disease, influenza and tuberculosis. The session will include both general overview talks on both CARB and AMD as well as specific talks as to how each initiative will be used in the study and understanding of antimicrobial resistance in N. gonorrhoeae.